Achilles Therapeutics plc Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q4 2021 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary: Achilles Therapeutics plc quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q4 2021 to Q2 2024.
Achilles Therapeutics plc Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending June 30, 2024 was $197K, a 61.1% decline year-over-year.

Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)

Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2024	$197K	-$309K	-61.1%	Jun 30, 2024	6-K	2024-08-14
Q4 2023	$201K	-$311K	-60.7%	Dec 31, 2023	20-F	2024-04-04
Q2 2023	$506K			Jun 30, 2023	6-K	2023-08-04
Q4 2022	$512K	-$386K	-43%	Dec 31, 2022	20-F	2023-03-07
Q4 2021	$898K			Dec 31, 2021	20-F	2022-03-01

* An asterisk sign (*) next to the value indicates that the value is likely invalid.